image
Cogent Biosciences, Inc. COGT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.355
-1.6 %
$ 496 M
Market Cap
-2.22
P/E
Price Target Average
238.69%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
34.42%
Net Income Estimate
21.84%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Cogent Biosciences, Inc.
image
Wall Street analysts predict an average 1-year price target for COGT of $14.8 , with forecasts ranging from a low of $13 to a high of $17 .
COGT Lowest Price Target Wall Street Target
13 USD 198.51%
COGT Average Price Target Wall Street Target
14.8 USD 238.69%
COGT Highest Price Target Wall Street Target
17 USD 290.36%
Price
Max Price Target
Min Price Target
Average Price Target
18181616141412121010886644Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart COGT

image
$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.020182018201920192020202020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart COGT

image
$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)20182018201920192020202020232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart COGT

image
$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)20182018201920192020202020232023202420242025202520262026202720272028202820292029